Stanford Women's Cancer Center — Palo Alto, California

Stanford Women's Cancer Center is a clinical research site located in Palo Alto, California, United States 94305.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford Women's Cancer Center has participated in 14 clinical trials with 11 currently active.

Therapeutic areas: Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Sponsors: Eli Lilly and Company, Pfizer, Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Women's Cancer Center?

Stanford Women's Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Women's Cancer Center conducted?

Stanford Women's Cancer Center has 14 clinical trials on record, with 11 currently active. Their work covers Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Is Stanford Women's Cancer Center accredited by Crixeo Clinical Trials?

Stanford Women's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Women's Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.